Effects of canagliflozin on heart failure outcomes with and without preserved ejection fraction in type 2 diabetes: results from the canvas program
Author(s)
Type
Conference Paper
Date Issued
2019-03-12
Date Acceptance
2019-03-01
Citation
Journal of the American College of Cardiology, 2019, 73 (9), pp.685-685
ISSN
0735-1097
Publisher
Elsevier
Start Page
685
End Page
685
Journal / Book Title
Journal of the American College of Cardiology
Volume
73
Issue
9
Copyright Statement
Copyright © 2019 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. This manuscript is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Licence http://creativecommons.org/licenses/by-nc-nd/4.0/
Identifier
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000460565900685&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
Source
68th Annual Scientific Session and Expo of the American-College-of-Cardiology (ACC)
Subjects
Science & Technology
Life Sciences & Biomedicine
Cardiac & Cardiovascular Systems
Cardiovascular System & Cardiology
Publication Status
Published
Start Date
2019-03-16
Finish Date
2019-03-18
Coverage Spatial
New Orleans, LA
Date Publish Online
2019-03-04